ComFyt, the revolution in compression therapy. A novel Electro-Active Polymers technology applied to a smart stocking that mimics rhythmic calf muscle contractions and stimulates the blood flow.

Projektinformationen

ComFyt

ID Finanzhilfevereinbarung: 812092

DOI 10.3030/812092

Projekt abgeschlossen

EK-Unterschriftsdatum 15 Mai 2018

Startdatum 1 Juni 2018

Enddatum 30 Juni 2020

Finanziert unter

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Gesamtkosten € 1 908 775,00

EU-Beitrag € 1 336 142,50

Koordiniert durch

ELASTIMED LTD
Israel

Ziel

The innovation consists in the proprietary method and mechanism for maintaining the smart material- Electroactive Polymers
(EAP) - in a pre-stretch state. This revolutionary technology manipulates the EAP film into thin, linear actuators, for
integration in numerous healthcare devices. Highly suitable for wearable devices, the EAPs expand and contract when
stimulated by an electric field.
ComFyt - the first application of our innovation - is a smart stocking designed for venous disease patients. ComFyt can be
worn throughout the day everywhere. It massages the leg mimicking calf muscle contractions and treating potentially life
threatening circulatory conditions. Its agility and flexibility solves the problem of low compliance and comfort of the current
compression therapy devices.
Blood circulation is a crucial part of the human anatomy, ensuring nutrient and oxygen delivery to all the cells in the body.
Poor circulation can cause painful VDs, such as edema, varicose veins, lymphedema, and multiple sports injuries, which
greatly affect the patient’s quality of life. Life threatening disorders, such as Chronic Venous Insufficiency and Deep Vein
Thrombosis (DVT) are serious conditions caused by compromised circulation too. Every year, approximately 10 million
people suffer from DVT worldwide.

Wissenschaftliches Gebiet

• natural sciences › computer and information sciences › internet › internet of things
• medical and health sciences › basic medicine › anatomy and morphology
• medical and health sciences › clinical medicine › angiology › vascular diseases
• social sciences › political sciences › political transitions › revolutions
• natural sciences › chemical sciences › polymer sciences

Programm/Programme

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Thema/Themen

• EIC-SMEInst-2018-2020 - SME instrument

Aufforderung zur Vorschlagseinreichung

H2020-EIC-SMEInst-2018-2020

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEInst-2018-2020-2

Finanzierungsplan

SME-2 - SME instrument phase 2

Koordinator

ELASTIMED LTD

• Netto-EU-Beitrag: € 1 336 142,50
• Adresse: HATCHELET 17 ; 2017900 MISGAV IP ; Israel
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Aktivitätstyp
  Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 1 908 775,00